Bibliographic Info
GuidelineUpdated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year of Publication2018
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Low
Adults and adolescents. When available, atazanavir/r (ATV/r), darunavir/r (DRV/r), lopinavir/r (LPV/r) and RAL may be considered as alternative third drug options for post-exposure prophylaxis
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO
Guideline
Guidelines for HIV post-exposure prophylaxis
Year2025
InstitutionWorld Health Organization